Long-term use of adalimumab in the treatment of rheumatic diseases
Charalampos Papagoras, Paraskevi V Voulgari, Alexandros A DrososRheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, GreeceAbstract: Adalimumab, a fully humanized monoclonal antibody against tumor necrosis factor-alpha (TNF&alph...
Main Authors: | Charalampos Papagoras, Paraskevi V Voulgari, Alexandros A Drosos |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-05-01
|
Series: | Open Access Rheumatology : Research and Reviews |
Online Access: | http://www.dovepress.com/long-term-use-of-adalimumab-in-the-treatment-of-rheumatic-diseases-a3155 |
Similar Items
-
Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis
by: Kotaniemi K, et al.
Published: (2011-10-01) -
Rheumatoid Arthritis Treatment. A Back to the Drawing Board Project or High Expectations for Low Unmet Needs?
by: Alexandros A. Drosos, et al.
Published: (2019-08-01) -
Long-term treatment of rheumatoid arthritis with adalimumab
by: Murdaca G, et al.
Published: (2013-05-01) -
Periocular xanthogranuloma: A forgotten entity?
by: Charalampos Papagoras, et al.
Published: (2010-03-01) -
Golimumab for Rheumatoid Arthritis
by: Eleftherios Pelechas, et al.
Published: (2019-03-01)